Treatment of Ureaplasma Vaginitis
For Ureaplasma urethritis/cervicitis, treat with either azithromycin 1 g orally as a single dose OR doxycycline 100 mg orally twice daily for 7 days, as these are the CDC-recommended first-line regimens for nongonococcal urethritis caused by Ureaplasma. 1
Important Clinical Clarification
Ureaplasma does not cause true "vaginitis"—it causes urethritis in men and cervicitis/urethritis in women. The term "Ureaplasma vaginitis" is a misnomer; Ureaplasma urealyticum is a cause of nongonococcal urethritis (NGU) and mucopurulent cervicitis, not vaginitis. 1
First-Line Treatment Regimens
Recommended Options (Equal Efficacy)
Azithromycin 1 g orally in a single dose 1
Doxycycline 100 mg orally twice daily for 7 days 1
- Highly effective with 98.2% susceptibility rates for U. urealyticum 4
- Standard multi-day regimen
Alternative Regimens (When First-Line Cannot Be Used)
- Erythromycin base 500 mg orally four times daily for 7 days 1
- Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1
- Levofloxacin 500 mg orally once daily for 7 days 1
- Ofloxacin 300 mg orally twice daily for 7 days 1
Important Caveat About Alternatives
Erythromycin and azithromycin show variable susceptibility patterns for Ureaplasma, with some studies showing poor activity. 4 However, azithromycin remains guideline-recommended due to its unique pharmacokinetics and clinical trial data. 1, 2, 3
Recurrent or Persistent Infection
If symptoms persist after initial treatment and reinfection/non-compliance are excluded:
- Metronidazole 2 g orally in a single dose PLUS azithromycin 1 g orally in a single dose (if azithromycin not used initially) 1
Critical Management Points
Partner Management
- All sexual partners within the preceding 60 days must be evaluated and treated 1
- Partner treatment is essential to prevent reinfection
Sexual Abstinence
- Patients must abstain from sexual intercourse until 7 days after therapy is initiated AND symptoms have resolved AND partners have been adequately treated 1
Follow-Up Criteria
- Return for evaluation only if symptoms persist or recur after completing therapy 1
- Symptoms alone without objective signs (urethral discharge, >5 PMNs per high-power field on urethral smear) are not sufficient basis for re-treatment 1
Special Populations
HIV-Infected Patients
- Use the same treatment regimens as HIV-negative patients 1
- Ureaplasma urethritis may facilitate HIV transmission 1
Pregnancy
- Azithromycin 1 g single dose is ineffective for reducing lower genital U. urealyticum colonization in pregnancy 5
- For pregnant women when tetracyclines are contraindicated: Erythromycin base 500 mg orally four times daily for at least 7 days 6
- Alternative for intolerance: Erythromycin 500 mg every 12 hours or 250 mg four times daily for at least 14 days 6
Common Pitfalls to Avoid
Do NOT treat asymptomatic colonization—Ureaplasma can be part of normal genital flora 1
Do NOT confuse with bacterial vaginosis or candidal vaginitis—these require different treatments (metronidazole/clindamycin for BV, antifungals for candidiasis) 1, 7
Do NOT rely on fluoroquinolones as first-line—ofloxacin and ciprofloxacin show poor activity against most U. urealyticum strains 4
Do NOT forget to test for co-infections—test for N. gonorrhoeae and C. trachomatis, as these frequently co-exist 1
Ensure objective signs are present before re-treatment—persistent symptoms without laboratory evidence of inflammation do not warrant additional antimicrobials 1